|Bid||130.97 x 2300|
|Ask||130.99 x 100|
|Day's Range||130.61 - 131.61|
|52 Week Range||106.87 - 133.55|
|PE Ratio (TTM)||64.52|
|Expense Ratio (net)||0.06%|
According to a Deloitte report, the biosimilars market is expected to grow to a market value of more than $445.0 billion by the end of 2019.
Becton, Dickinson and Company (BDX) closed at $196.62 on September 13, 2017.
This year, the growth factor resumed its outperformance of the value factor, benefiting a host of exchange traded funds along the way. Investors can easily access growth stocks via ETFs, whether be by ...